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Abstract. – OBJECTIVE: The aim of our study 
was to search for evidence of a "staphylo-
coccus superantigen" in chronic rhinosinusitis 
with nasal polyps.  
PATIENTS AND METHODS: Sixty-nine pa-
tients with chronic rhinosinusitis with nasal 
polyps and 45 healthy controls were includ-
ed in the study. All patients in the study and 
control groups underwent bacteriological and 
immunological examination on nasal smear 
samples. Total IgE and the following cytokines 
were tested in all patients: tumor necrosis fac-
tor (TNF), interleukin-1 (IL1), interleukin-6 (IL6), 
interleukin-8 (IL8).
RESULTS: The concentration of bacteria in 
the nasal cavity was much higher in patients 
in the study group compared to those in the 
control group, mainly due to staphylococci. In 
species identification of staphylococci, bacte-
ria most represented were S. aureus and S. 
epidermidis. The greater the concentration of 
S. aureus, the lower the level of IgE. Proinflam-
matory cytokines were uniformly increased in 
patients with nasal polyps. The level of IgE was 
maximal in patients with chronic rhinosinusitis 
with nasal polyps with a poor growth of culture 
and minimal in patients with abundant growth, 
suggesting that in the latter the effect of eosino-
philic inflammation on the disease was reduced, 
and conversely, the activity of eosinophilic in-
flammation was maximal with a poor seeding of 
the nasal cavity. 
CONCLUSIONS: Although this study has some 
limits, our findings do not support the theory of 
a staphylococcus superantigen in which the IgE 
level and eosinophilic inflammation should in-
crease with increasing activity of Staphylococ-
cus aureus. Further research supported by a 
larger sample of patients is required to better 
delineate the role of a staphylococcus superan-
tigen in the pathogenesis of patients with chron-
ic rhinosinusitis with nasal polyps.
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Introduction
Chronic rhinosinusitis with nasal polyps is a 
chronic disease of the nasal mucosa and parana-
sal sinuses; it has an inflammatory reaction on the 
level of pathogenesis, in which, depending on the 
form of inflammation, eosinophils or neutrophils 
may predominate1-4. Its prevalence in the popu-
lation is quite high and may have a significant 
impact on quality of life5. In Skovde (Sweden), 
the prevalence of nasal polyps is 2.7% of the total 
population6. In Finland, it was determined that 
4.3% of the adult population responded positively 
to the question of whether they ever had polyps 
in the nasal cavity7. In Denmark, polyps in the 
nasal cavity were found in 5 out of 19 autopsy 
cases8. In France, using a questionnaire specific 
to each disease, a 2.1% prevalence of nasal polyps 
was found in the general population9. Endoscopic 
Sinus Surgery (ESS) is widespread in treating 
chronic rhinosinusitis with nasal polyps and sev-
eral studies have shown that it is an effective and 
safe treatment for patients with chronic rhinosi-
nusitis with nasal polyps when drug therapy has 
European Review for Medical and Pharmacological Sciences
K. DOBRETSOV1, H. NEGM2, M. RALLI3, D. PASSALI4
1Center of Otorhinolaryngology of Federal Siberian Scientific Clinical Centre of FMBA of Russia, 
 Moscow, Russia
2Otorhinolaryngology Department, Faculty of Medicine, Cairo University, Cairo, Egypt
3Department of Sense Organs, Sapienza University of Rome, Rome, Italy
4Department of Medicine, Surgery and Neuroscience, ENT Clinic, University of Siena, Siena, Italy
Corresponding Author: Massimo Ralli, MD; e-mail: massimo.ralli@uniroma1.it
The theory of a "staphylococcus superantigen" 
in chronic rhinosinusitis with nasal polyps: 
myth or reality?  
2019; 23(1 Suppl.): 48-54
Staphylococcus superantigen in chronic rhinosinusitis
49
failed10-14. Despite widespread occurrence, there 
is still no single point of view about the causes of 
nasal polyposis. Recently, some researchers ad-
hered to the theory of a so-called “staphylococcus 
superantigen”, which suggests that colonization 
by S. aureus leads to the formation of a super-
antigenic toxin that enhances local eosinophilic 
inflammation and the formation of polyps15-24. In 
support of this hypothesis, studies have shown a 
high correlation between the presence of staphy-
lococci and polyps of the nose15,16,25.
However, evidence for the role of a staphylo-
coccus superantigen in the pathogenesis of nasal 
polyps is still insufficient. The aim of our study was 
to search for evidence of a staphylococcus super-
antigen in chronic rhinosinusitis with nasal polyps. 
Patients and Methods
Patients
Sixty-nine patients with chronic rhinosinus-
itis with nasal polyps aged from 18 to 70 years 
of both sexes were included in the study. The 
control group included 45 healthy volunteers that 
matched the study group for sex and age. The 
study was performed in the Otolaryngology De-
partment of our University Hospital; the study 
was specifically approved by the Ethical Com-
mittee of our University.
All patients in the study group entered the 
otolaryngology department for routine ESS treat-
ment. Term of the disease in patients did not ex-
ceed 5 years; patients with earlier operations for 
polyposis were excluded from the study. All pa-
tients in the study and control groups underwent 
bacteriological and immunological examination 
on nasal smear (before surgery for patients in the 
study group). To determine the effect of bacterial 
concentration on the level of eosinophilic in-
flammation, patients with chronic rhinosinusitis 
with nasal polyps were divided into three groups 
depending on the growth of microorganisms: 
14 patients with poor growth (20 colonies, 10x3 
units of colony-forming units (CFU)/ml)); 28 
patients (group 2) with moderate growth (21 to 
100 colonies, 10x4 CFU/ml); 27 patients (group 
3) with abundant growth (more than 100 colonies, 
from 10x4 CFU/ml). For a bacteriological study, 
a smear from the mucous membrane of the mid-
dle nasal passage was carried out, followed by 
sowing of microorganisms with the help of three 
nutrient differential diagnostic media. Total IgE 
and the following cytokines were tested in all pa-
tients: tumor necrosis factor (TNF), interleukin-1 
(IL1), interleukin-6 (IL6), interleukin-8 (IL8). 
Statistical Analysis
Statistical processing of the results was car-
ried out using the Statistica 7.0 application soft-
ware package (StatSoft, Inc., 2004). The sample 
was processed by calculating the median (Me) 
and interquartile range in the form of 25th and 
75th percentiles (C25 and C75). The reliability 
of the differences between the indices of inde-
pendent samples was estimated from the non-
parametric Mann-Whitney criterion, dependent 
samples using the Wilcoxon test. The critical 
level of significance (p) in testing the statistical 
hypotheses in this study was 0.05. 
Results
When studying the role of bacteria in pa-
tients with chronic rhinosinusitis with nasal 
polyps (study group), it was found that the to-
tal number of bacteria in these patients signifi-
cantly exceeded the microbial landscape of the 
nasal cavity of subjects in the control group; 
11,120,000 (6,051,004-516,650,004) CFU/ml vs. 
10,000 (1,160-23,000) CFU/ml p<0.001). With 
the generic identification of bacteria, the concen-
tration of staphylococci was dominant in both 
groups: 2,131,001 (1,600,000-4,520,002) CFU/ml 
in patients with chronic rhinosinusitis with na-
sal polyps and 10,000 (300-11,000) CFU/ml in 
healthy individuals. In species studies in healthy 
people, a higher titer showed S. epidermidis 1000 
(100-1,000) CFU/ml, which corresponds to the 
norm. In patients with polyposis, most bacteria 
of the genus Staphylococcus were represented by 
S. aureus 500,000 (400,000-3,500,000) CFU/ml 
and S. epidermidis 500,000 (120,000-1,000,000) 
CFU/ml (Table I). 
In spite of the fact that most bacteria were rep-
resented by staphylococci, in the species assess-
ment of microorganisms in general, St. pneumo-
niae 10,000,000 (500,000-7,000,000) CFU/ml and 
M. catarrhalis 10,000,000 (500,000-25,000,000) 
CFU/ml were dominant in patients with chronic 
rhinosinusitis with nasal polyps.  
When analyzing proinflammatory cytokines 
in patients in the study group, it was determined 
that all the cytokines tested were increased in 
comparison with subjects in the control group 
(Figure 1). This, undoubtedly, is associated with 
a pronounced inflammatory reaction to disease. 
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It was also noted that IL8, at 45 (25-110) pg/mg, 
increased most intensively, against 5 (2-8) pg/
mg in healthy individuals (p<0.01). IgE levels 
in patients in the study group were significantly 
higher than in the control group (Figure 2). The 
concentration in patients was 94 (17-165) IU/
ml, against 7 (3-10) IU/ml in healthy subjects 
(p<0.001). 
In patients with chronic rhinosinusitis with na-
sal polyps in the moderate- and abundant-growth 
groups, staphylococci also dominated, with values 
of 1,960,001 (1,465,051-2,321,001) CFU/ml and 
4,730,002 (3,020,000-9,020,000) CFU/ml, respec-
tively. However, unlike the groups as a whole, in 
patients with nasal polyps with abundant growth 
of microorganism, the highest concentration was 
in S. aureus - 3,500,000 (1,000,000-4,000,000) 
CFU/ml, both in species identification and among 
all microorganisms (Table II). 
In the study of proinflammatory cytokines, 
there was no significant association with colony 
growth in patients with chronic rhinosinusitis 
with nasal polyps. In the study group, investi-
gated cytokines (TNF, IL1, IL6, IL8) were uni-
formly increased in patients with nasal polyps. 
However, the level of IgE in the groups with 
different culture growth was different (Figure 3). 
It was maximal in patients with chronic rhinosi-
nusitis with nasal polyps with a poor growth of 
culture - 150 (45-310) ME/mg - and minimal in 
patients with abundant growth - 34 (16-117) ME/
mg (p<0.01). This suggests that in those patients 
where abundant growth of microorganisms is 
determined (due to the activity of S. aureus), 
the effect of eosinophilic inflammation on the 
disease was reduced, and conversely, the activity 
of eosinophilic inflammation was maximal with 
a poor seeding of the nasal cavity. 
Table I. The main indices of dissemination of the nasal cavity in the study group (n = 69) and in the control group (n=45) (Me 
[C25- C75]).
*p<0.01; **p<0.001.
Microorganisms (CFU/ml) Study group (n=69) Control group (n=45)
Staphylococcus 2,131,001 (1,600,000-4,520,002) 10,000 (300-11,000)
S. aureus 500,000 (400,000-3,500,000) 100 (33-200)**
S. epidermidis 500,000 (120,000-1,000,000) 1,000 (100-1,000)
S. haemolyticus 10,000 (10,000-100,000) 100 (10-100)**
Streptococcus 1,325,000 (500,000-8,500,000) 1,000 (1,000-1,000)**
St. pneumonia 1,000,000 (500,000-7,000,000) 1,000 (1,000-1,000)**
Micrococcus 5,000 (1,000-5,500) 1,000 (550-1,000)*
Enterobacteriaceae 10,000 (10,000-55,000) 1,000 (55-10,000)**
M. catarrhalis 1,000,000 (500,000-25,000,000) 1,000 (1,000-1,000)**
Figure 1. The level of proinflam-
matory cytokines (TNF, IL-1, IL-
6, IL-8) in patients in the study 
group and in the control group (* 
- p<0.001). 
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Discussion
In the study of microflora in patients with 
chronic rhinosinusitis with nasal polyps, it was 
found that their growth was increased due to 
gram-positive microorganisms, mainly staphylo-
cocci. The greatest number of bacteria was repre-
sented by St. pneumoniae and M. catarrhalis, and 
in staphylococci - S. aureus and S. epidermidis. 
All the studied proinflammatory cytokines were 
increased, which indicates the presence of a 
pronounced inflammatory process in polyposis; 
this is in accordance with recent studies that fo-
cused on the role of proinflammatory cytokines 
in nasal polyposis5,12-14,26-30. In particular, IL8 has 
pronounced proinflammatory properties, causes 
Figure 2. IgE concentration in 
patients in the study group and in 
the control group (* - p<0.001). 
Table II. The main indices of dissemination of the nasal cavity in patients with chronic rhinosinusitis with nasal polyps (n = 69, 
Me (C25-C75). Patients were divided in three groups depending on the growth of microorganisms (poor growth, moderate growth, 
abundant growth).
*p<0.01; **p<0.001.
Microorganisms  Poor growth Moderate growth Abundant growth
 (CFU/ml) 
Staphylococcus 1,530,050 1,960,001 4,730,002
 (1,510,000-1,631,000) (1,465,051-2,321,001) (3,020,002-9,020,002)*
S. aureus 50,000 450,000 3,500,000
 (10000-100000) (200,000-500,000) (1,000,000-4,000,000)**
S. epidermidis 500,000 400,000 1,000,000
 (10,000-1,000,000) (120,000-500,000) (500,000-3,750,000)
S. haemolyticus 55,000 10,000 10,000
 (10,000-100,000) (10,000-55,000) (10,000-110,000)*
Streptococcus 575,000 1,505,000 1,500,000
 (475,000-3,505,000) (500,000-22,500,000) (1,000,000-8,500,000
St. pneumonia 500,000 1,000,000 1,000,000
 (500,000-5,000,000) (500,000-25,000,000) (500,000-7,000,000)**
Micrococcus 7,750 5,500 1,000
 (3,250-10,000) (1,000-5,500) (1,000-3,000)
Enterobacteriaceae 32,500 55,000 10,000
 (10,000-77,500) (10,000-100,000) (10,000-55,000)
M. catarrhalis 1,250,000 1,000,000 1,000,000 
 (500,000-25,000,000) (500,000-25,000,000) (500,000-7,000,000)*
Hem. influenzae 1,250,000 750,000 750,000
 (500,000-25,000,000) (200,000-25,000,000) (500,000-7,000,000)
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the expression of intercellular adhesion mole-
cules, and enhances the adhesion of neutrophils 
to endothelial cells and subendothelial matrix 
proteins. The pronounced increase of IL8 in pa-
tients with nasal polyps is indicative of the role 
of neutrophilic inflammation in the disease 31-33. 
IgE levels in patients with chronic rhinosinusitis 
with nasal polyps were significantly higher than 
in healthy people. It is known that the activity 
of this immunoglobulin is due to eosinophilic 
inflammation, which plays an important role in 
chronic rhinosinusitis with nasal polyps 27,34-37.  
Much debate exists on the role of staphylococ-
cus aureus superantigens in chronic rhinosinus-
itis. A recent meta-analysis on 12 studies includ-
ing 340 cases and 178 controls that indicated that 
the staphylococcus aureus superantigens may be 
a risk factor for chronic rhinosinusitis with nasal 
polyps, and the presence of the staphylococcus 
aureus superantigen may be related to the disease 
severity of the disease 38. In our study, when pa-
tients were divided into three groups depending 
on the degree of dissemination, it was determined 
that the staphylococcus was also dominant, with a 
predominance of S. aureus in the moderate- and 
abundant-growth groups. This suggests that in 
the group with pronounced culture growth in pa-
tients with chronic rhinosinusitis with nasal pol-
yps, S. aureus plays the greatest role. Moreover, 
the inverse dependence of the IgE level on the 
level of dissemination of the mucous membrane 
of the nasal cavity was determined. 
The main limitation of the present study is 
the small sample size that may have affected the 
statistical power of our analysis.
Conclusions
Our results show that the higher the titer of 
nasal cavity colonization, the lower the activity of 
eosinophilic inflammation. These findings, that 
may be affected by the small sample size of the 
study group, do not confirm the theory of a staph-
ylococcus superantigen in which eosinophilic 
inflammation should increase with the activity 
of Staphylococcus aureus. Further research sup-
ported by a larger sample of patients is required 
to better delineate the role of a staphylococcus 
superantigen in the pathogenesis of patients with 
chronic rhinosinusitis with nasal polyps.
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